ライフサイエンスコーパス: multidrug-resistant strain

1 multiple M. tuberculosis strains (including multidrug-resistant strains).

2 tridium difficile strain 630, a virulent and multidrug-resistant strain.

3 ferring antibiotic resistance and generating multidrug resistant strains.

4 be lethal due to the global dissemination of multidrug resistant strains.

5 s of function was observed exclusively among multidrug-resistant strains.

6 azole drugs, resulting in difficult-to-treat multidrug-resistant strains.

7 s steadily increased, with a predominance of multidrug-resistant strains.

8 ing colonization and subsequent infection by multidrug-resistant strains.

9 This applies also to multidrug-resistant strains.

10 f outbreaks and aid in the identification of multidrug-resistant strains.

11 han female individuals to be infected with a multidrug-resistant strain (7% versus 3%; P < .01).

12 ones, beta-lactam/beta-lactamase inhibitors, multidrug resistant strains and carbapenem-resistant Ent

13 increasingly difficult due to the spread of multidrug resistant strains and thus requires a deeper u

14 l activity against N. gonorrhoeae, including multidrug-resistant strains and key Gram-positive, fasti

15 ated for antiplasmodial activity against K1 (multidrug resistant strain) and NF54 (sensitive strain).

16 is isolates (including both pansensitive and multidrug-resistant strains) and the H37Rv strain by usi

17 gainst Mycobacterium tuberculosis, including multidrug-resistant strains, and some species of nontube

18 pensity to develop antibiotic resistance and multidrug resistant strains are endemic in hospitals.

19 to human health because of the emergence of multidrug-resistant strains associated with hospital out

20 fatality ratio, and the common detection of multidrug-resistant strains call for a need to improve t

21 The high prevalence of multidrug-resistant strains calls for improvement in env

22 e show that in synchronized PDR1 and pdr1-3 (multidrug resistant) strains, cellular efflux of a known

23 iance often leads to therapeutic failure and multidrug resistant strain development.

24 R4 by using whole genomic DNA extracted from multidrug-resistant strain GA71, a serotype 19F variant

25 Acinetobacter baumannii infection, including multidrug-resistant strains, has inconclusive impact on

26 to therapy, and the increasing frequency of multidrug-resistant strains have necessitated the search

27 cations of Acinetobacter baumannii including multidrug-resistant strains in patients were compared to

28 The emergence of multidrug-resistant strains is an increasing danger to p

29 irds and, in one case, identical to a highly multidrug resistant strain isolated from a human child.

30 ding UPEC, and is frequently associated with multidrug-resistant strains, it represents a promising n

31 compounds possess potent activity against a multidrug resistant strain of P. falciparum and arrest p

32 treat most patients, the rapid emergence of multidrug resistant strains of Mycobacterium tuberculosi

33 e and assessed for in vitro activity against multidrug resistant strains of Plasmodium falciparum and

34 s have potent antibacterial activity against multidrug resistant strains of S. aureus, and compound 3

35 al activity against NF54 (sensitive) and K1 (multidrug resistant) strains of the malaria parasite Pla

36 Here, we show that several multidrug-resistant strains of A. baumannii harbor a lar

37 However, multidrug-resistant strains of bacterial bioterrorism ag

38 risons and microbiological data suggest that multidrug-resistant strains of gram-positive cocci emplo

39 Triclosan and its analogs 1 and 2 killed multidrug-resistant strains of intra-erythrocytic P. fal

40 ns are a large proportion of HAI agents, and multidrug-resistant strains of Klebsiella pneumoniae, a

41 The recent outbreaks of multidrug-resistant strains of M. tuberculosis in health

42 s consisting of five drug-sensitive and five multidrug-resistant strains of M. tuberculosis, with 6 b

43 nd is further restricted by the emergence of multidrug-resistant strains of M. tuberculosis.

44 creasingly complicated with the emergence of multidrug-resistant strains of Mycobacterium tuberculosi

45 tuberculosis drug, active against a range of multidrug-resistant strains of Mycobacterium tuberculosi

46 ed by the HIV/AIDS pandemic and emergence of multidrug-resistant strains of Mycobacterium tuberculosi

47 ich includes an increase in the isolation of multidrug-resistant strains of Mycobacterium tuberculosi

48 t in antimicrobial activity observed against multidrug-resistant strains of Pseudomonas aeruginosa an

49 ificity efflux pumps have been implicated in multidrug-resistant strains of Pseudomonas aeruginosa an

50 ar potency against both drug-susceptible and multidrug-resistant strains of the tubercle bacillus.

51 Multidrug-resistant strains of Vibrio cholerae (the caus

52 th an isoniazid-resistant (as a surrogate of multidrug-resistant) strain of Mycobacterium tuberculosi

53 ctivity against the 3D7 (sensitive) and Dd2 (multidrug-resistant) strains of Plasmodium falciparum wi

54 its over monotherapy, it may also select for multidrug-resistant strains, particularly during long-te

55 ncern, exacerbated by the rapid emergence of multidrug resistant strains refractory to antibiotic tre

56 s, and (ii) because of this incompatibility, multidrug-resistant strains sharing features found in V5

57 nly employed in the clinic and the growth of multidrug resistant strains suggest that the development

58 However, fitter multidrug-resistant strains that emerge over time may ma

59 s been aggravated by the recent emergence of multidrug-resistant strains, thus stressing the need for

60 The susceptibility of a multidrug resistant strain toward these compounds and th

61 osis strains CDC1551, Erdman, and H37Rv, and multidrug-resistant strain W.

62 at prolonged patient treatment can result in multidrug-resistant strains with no fitness defect and t